AR209575A1 - Un procedimiento para preparar nuevos derivados sustituidos de 5-,6-,7-u8-(3-amino-2-oxisustituido)-propoxi-3,4-dihidrocarbostirilo y de 5-,6-,7-u8-(3-amino-2-hidroxi)propoxi -3,4-dihidrocarbostirilo - Google Patents

Un procedimiento para preparar nuevos derivados sustituidos de 5-,6-,7-u8-(3-amino-2-oxisustituido)-propoxi-3,4-dihidrocarbostirilo y de 5-,6-,7-u8-(3-amino-2-hidroxi)propoxi -3,4-dihidrocarbostirilo

Info

Publication number
AR209575A1
AR209575A1 AR246548A AR24654873A AR209575A1 AR 209575 A1 AR209575 A1 AR 209575A1 AR 246548 A AR246548 A AR 246548A AR 24654873 A AR24654873 A AR 24654873A AR 209575 A1 AR209575 A1 AR 209575A1
Authority
AR
Argentina
Prior art keywords
amino
oxisustitido
dihydrocarbostirile
dihidrocarbostirilo
propoxi
Prior art date
Application number
AR246548A
Other languages
English (en)
Spanish (es)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9255772A external-priority patent/JPS5324431B2/ja
Priority claimed from JP47092560A external-priority patent/JPS5246231B2/ja
Priority claimed from JP47092558A external-priority patent/JPS5241268B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of AR209575A1 publication Critical patent/AR209575A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR246548A 1972-04-13 1973-02-12 Un procedimiento para preparar nuevos derivados sustituidos de 5-,6-,7-u8-(3-amino-2-oxisustituido)-propoxi-3,4-dihidrocarbostirilo y de 5-,6-,7-u8-(3-amino-2-hidroxi)propoxi -3,4-dihidrocarbostirilo AR209575A1 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP47037181A JPS517672B2 (da) 1972-04-13 1972-04-13
JP47037182A JPS48103590A (da) 1972-04-13 1972-04-13
JP9255772A JPS5324431B2 (da) 1972-09-14 1972-09-14
JP47092560A JPS5246231B2 (da) 1972-09-14 1972-09-14
JP47092558A JPS5241268B2 (da) 1972-09-14 1972-09-14
JP47120953A JPS5229745B2 (da) 1972-04-13 1972-12-02
JP47125858A JPS5239036B2 (da) 1972-04-13 1972-12-14
JP47128972A JPS5241269B2 (da) 1972-04-13 1972-12-21

Publications (1)

Publication Number Publication Date
AR209575A1 true AR209575A1 (es) 1977-05-13

Family

ID=27572212

Family Applications (1)

Application Number Title Priority Date Filing Date
AR246548A AR209575A1 (es) 1972-04-13 1973-02-12 Un procedimiento para preparar nuevos derivados sustituidos de 5-,6-,7-u8-(3-amino-2-oxisustituido)-propoxi-3,4-dihidrocarbostirilo y de 5-,6-,7-u8-(3-amino-2-hidroxi)propoxi -3,4-dihidrocarbostirilo

Country Status (17)

Country Link
JP (5) JPS517672B2 (da)
AR (1) AR209575A1 (da)
AU (1) AU475964B2 (da)
BE (1) BE794669A (da)
CA (1) CA1025447A (da)
CH (1) CH575929A5 (da)
DD (2) DD112446A5 (da)
DE (1) DE2302027C2 (da)
DK (1) DK141603B (da)
FI (1) FI53703C (da)
FR (1) FR2179715B1 (da)
GB (2) GB1424572A (da)
HK (1) HK19481A (da)
NL (1) NL158176B (da)
NO (1) NO140589C (da)
SE (1) SE380018B (da)
YU (1) YU41187B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5082218A (da) * 1973-11-10 1975-07-03
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US4137331A (en) 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
JPS516971A (en) * 1974-07-08 1976-01-20 Otsuka Pharma Co Ltd Nitoro 3*44 jihidorokarubosuchirirujudotaino seizoho
JPS5129486A (en) * 1974-09-02 1976-03-12 Otsuka Pharma Co Ltd * 33 arukiruamino 22 hidorokishi * purohokishi 3 44 jihidorokarubosuchirirujudotai no seizoho
JPS5148674A (en) * 1974-10-17 1976-04-26 Otsuka Pharma Co Ltd 3 44 jihidorokarubosuchirirujudotaino seizoho
JPS5152180A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152179A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
JPS5152178A (ja) * 1974-10-31 1976-05-08 Otsuka Pharma Co Ltd Karubosuchirirujudotaino seizoho
FI58329C (fi) * 1974-11-08 1981-01-12 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av i 8-staellning substituerade 5-(3'-alkylamino-2'-hydroxi)propoxi-3,4-dihydrokarbostyrilderivat
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH619453A5 (da) * 1976-03-17 1980-09-30 Otsuka Pharma Co Ltd
GB1574665A (en) * 1976-05-08 1980-09-10 Otsuka Pharma Co Ltd 3,4-dihydrocarbostyril derivatives and process for preparing the same
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
EP0005828B1 (de) * 1978-06-06 1981-03-11 Hoechst Aktiengesellschaft Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
DE2827566A1 (de) * 1978-06-23 1980-01-10 Boehringer Mannheim Gmbh 1,2-dihydro-chinolin-2-on-derivate und verfahren zu ihrer herstellung
AU518814B2 (en) * 1979-01-30 1981-10-22 Otsuka Pharamaceutical Co. Glaucoma treatment
DE3034237A1 (de) * 1979-09-18 1981-04-16 Otsuka Pharmaceutical Co. Ltd., Tokyo Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
JPS58103343A (ja) * 1981-12-15 1983-06-20 Ota Seiyaku Kk プロパノ−ルアミン化合物の製造法
JPS597186A (ja) * 1982-07-02 1984-01-14 Ota Seiyaku Kk 1,3,2−ジオキサチオラン2−オキシド誘導体
JPS63193086U (da) * 1987-05-30 1988-12-13
DE3808136A1 (de) * 1988-03-11 1989-09-21 Thomae Gmbh Dr K Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung
US5266577A (en) * 1988-08-10 1993-11-30 Otsuka Pharmaceutical Company Ltd. Method of treating congestive heart failure using carbostyril derivatives
EP0355583B1 (en) * 1988-08-10 1995-01-25 Otsuka Pharmaceutical Co., Ltd. Cardiotonics
CA2093633A1 (en) * 1991-08-23 1993-02-24 Seiji Sato Carbostyril derivative and platelets aggregation inhibitory agent
ES2048108B1 (es) * 1992-07-17 1994-10-01 Lusochimica Spa Procedimiento para la preparacion de 5-(3-terc-butilamino-2-hidroxipropoxi)-3,4-dihidrocarboestirilo.
IT1264816B1 (it) * 1993-07-28 1996-10-10 Pergam Srl Procedimento per la preparazione di derivati del procedimento per la preparazione di derivati del 3,4-diidrocarbostirile 3,4-diidrocarbostirile
CZ300351B6 (cs) * 2005-05-26 2009-04-29 Zentiva, A. S. Zpusob prípravy 7-hydroxy-3,4-dihydrokarbostyrilu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1058822A (en) * 1963-07-30 1967-02-15 Ici Ltd 3-amino-2-hydroxypropoxy heterocyclic derivatives
CH523899A (de) * 1968-07-05 1972-06-15 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 2-Oxo-1,2-dihydro-chinolins

Also Published As

Publication number Publication date
DE2302027C2 (de) 1983-03-17
JPS5241269B2 (da) 1977-10-17
JPS5229745B2 (da) 1977-08-03
CH575929A5 (da) 1976-05-31
DD112446A5 (da) 1975-04-12
SE380018B (da) 1975-10-27
JPS5239036B2 (da) 1977-10-03
NO140589B (no) 1979-06-25
AU5438673A (en) 1974-10-17
NL158176B (nl) 1978-10-16
JPS48103590A (da) 1973-12-25
FI53703B (da) 1978-03-31
BE794669A (fr) 1973-05-16
NL7302353A (da) 1973-10-16
AU475964B2 (en) 1976-09-09
GB1424572A (en) 1976-02-11
YU254979A (en) 1982-10-31
FR2179715B1 (da) 1976-12-03
JPS517672B2 (da) 1976-03-10
GB1424571A (en) 1976-02-11
JPS4981373A (da) 1974-08-06
DK141603C (da) 1980-10-06
HK19481A (en) 1981-05-22
FR2179715A1 (da) 1973-11-23
DK141603B (da) 1980-05-05
NO140589C (no) 1979-10-03
DD108293A5 (da) 1974-09-12
YU41187B (en) 1986-12-31
JPS4982673A (da) 1974-08-08
JPS48103589A (da) 1973-12-25
JPS4976878A (da) 1974-07-24
CA1025447A (en) 1978-01-31
DE2302027A1 (de) 1973-12-06
FI53703C (fi) 1978-07-10

Similar Documents

Publication Publication Date Title
AR209575A1 (es) Un procedimiento para preparar nuevos derivados sustituidos de 5-,6-,7-u8-(3-amino-2-oxisustituido)-propoxi-3,4-dihidrocarbostirilo y de 5-,6-,7-u8-(3-amino-2-hidroxi)propoxi -3,4-dihidrocarbostirilo
AR208768A1 (es) Un procedimiento para preparar nuevos derivados de la 4-amino-3-sulfonamido-piridina
AR210990A1 (es) Procedimiento para preparar derivados de 1,1-dihideoperflujoroalcobenzamidas n-pirrolidin- o piperidin- sustituidas
AR221816A1 (es) Metodo para preparar nuevos derivados de bencimidazol-2-carbamato-5(6)-sustituidos
AR205129A1 (es) Procedimiento para preparar nuevos derivados de chalcona
AR204982A1 (es) Procedimiento para preparar nuevos derivados de 1-fenoxi-2hidroxi-3-isopropilamina
AR195314A1 (es) Procedimiento para preparar derivados de piperidinoalcanol alfa-aril-4-sustituidos
AR200347A1 (es) Procedimiento para preparar derivados de la piperazina
AR194803A1 (es) Un procedimiento para preparar urea
AR203991A1 (es) Procedimiento para preparar derivados de(hidroxi-2-amino-3-propoxi)-3-isoindolinona-1
AR211257A1 (es) Un procedimiento para preparar derivados de 6-mentil-8-alcoxicarbonil-ergolina y de la 6-metil-8-aloxicarbonil-9-ergoleno
AR203500A1 (es) Procedimiento para preparar nuevos derivados de n-aminoalquil-2-aminoindano
AR201414A1 (es) Procedimiento para preparar nueevos derivados amidoximicos
AR211379Q (es) Procedimiento para preparar derivados de imidazolidin -4- onas -1, 3- disustituidas
AR210133A1 (es) Procedimiento para preparar nuevos derivados de 3-amino-5-metil-pirrol
AR200963A1 (es) Procedimiento para preparar nuevos derivados de alfa-l-arabinosido de digitoxigenina
AR208186A1 (es) Procedimiento para preparar nuevos derivados de (2-hidroxi-3-alquilamino propoxi)isocromanona
AR201666A1 (es) Procedimiento para preparar derivados de dimetiltetrahidronaftodioxolil-oxi-propanoles
SE391516B (sv) Forfarande for framstellning av bensylaminderivat
AR206653A1 (es) Procedimiento para preparar nuevos derivados de n-aminoalquil-2-amino-indano
AR211319A1 (es) Procendimiento para preparar derivados de 8-aza-9-oxo(y dioxo)-tia-11,12-secoprostaglandinas
AR192932A1 (es) Un procedimiento para la preparacion de derivados benzofuranicos
AR206584A1 (es) Un procedimiento para la obtencion de derivados de 5-fenil-1,4-benzodiazepin-2-onas
AR219471A1 (es) Procedimiento para preparar derivados 6-desoxi-6-azido-7,8-dihidroisomorfinicos y 6-desoxi-6-azido-14-hidroxi-7,8-dihidroisomorfinicos
AR207142A1 (es) Un procedimiento para la preparacion de nuevos derivados de n-fenil-n-aminoalquil-2-aminoindano